Title: Specimen: Blood Diagnosis: Endocarditis Enterococcus faecalis
1Specimen BloodDiagnosis EndocarditisEnteroc
occus faecalis
Case 11
- ampicillin S
- vancomycin S
- gentamicin synergy S
- streptomycin synergy S
Should we add any comment to the report?
2Enterococcus spp. CLSI Rx Comment
- Rx Combination therapy of ampicillin,
penicillin, or vancomycin (for susceptible
strains), plus an aminoglycoside, is usually
indicated for serious enterococcal infections,
such as endocarditis, unless high-level
resistance to both gentamicin and streptomycin is
documented such combinations are predicted to
result in synergistic killing of the
enterococcus.
CLSI M100-S21. Table 2D.
3(No Transcript)
4Enterococcus spp. HLAR (Synergy) Screening
- Disk diffusion
- 120 µg gentamicin 300 µg streptomycin
- ? 10 mm NO HLAR
- 6 mm HLAR
- 7-9 mm inconclusive perform MIC
- MIC screen
- gentamicin 500 µg/ml
- streptomycin 1000 µg/ml (broth) 2000 µg/ml
(agar) - no growth NO HLAR
- Perform testing when combination therapy is
desired (e.g., endocarditis)
5Enterococcus spp. Aminoglycoside-Modifying
Enzymes
- strep gent tob amk/kan
- 6-AAD - - -
- 3APH - - - (test
kan) - 2APH/6AAC -
- 6AAC - -
- found in all E. faecium
enzyme modifies drug drug NOT synergistic -
enzyme does not modify drug drug synergistic
6Enterococcus spp.
HLAR Test
- Gent Strep Choice of aminoglycoside
- S S either
- S R gentamicin
- R S streptomycin
- R R none
- HLAR to gentamicin confers HLAR to amikacin and
tobramycin
7Enterococcus spp. Predicting Synergy
Aminoglycoside or HLAR screen
- Susc Res
- Susc synergy no synergy
- Res no synergy no synergy
Cell wall active agent
ampicillin, penicillin, or vancomycin
8Specimen BloodDiagnosis EndocarditisEnteroc
occus faecalis
Final Report
Case 11
- ampicillin S
- vancomycin S
- gentamicin synergy S
- streptomycin synergy S
Serious enterococcal infections need combination
therapy with ampicillin or vancomycin plus an
aminoglycoside. Synergy occurs only when both
drugs in the combination are S